Integrated Diagnostics Holdings plc
IDGXF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $1,771,344 | $1,771,344 | $1,610,951 | $1,610,951 |
| % Growth | 0% | 10% | 0% | – |
| Cost of Goods Sold | $1,026,703 | $1,026,703 | $982,626 | $982,626 |
| Gross Profit | $744,642 | $744,642 | $628,326 | $628,326 |
| % Margin | 42% | 42% | 39% | 39% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $196,302 | $196,302 | $170,468 | $170,468 |
| SG&A Expenses | $301,791 | $301,791 | $260,536 | $260,536 |
| Sales & Mktg Exp. | $96,651 | $96,651 | $74,512 | $74,512 |
| Other Operating Expenses | -$12,729 | -$12,729 | -$21,917 | -$21,917 |
| Operating Expenses | $289,062 | $289,062 | $238,620 | $238,620 |
| Operating Income | $455,580 | $455,580 | $389,706 | $389,706 |
| % Margin | 25.7% | 25.7% | 24.2% | 24.2% |
| Other Income/Exp. Net | $1,047 | $1,047 | -$13,598 | -$13,598 |
| Pre-Tax Income | $456,627 | $456,627 | $376,108 | $376,108 |
| Tax Expense | $170,980 | $170,980 | $111,956 | $111,956 |
| Net Income | $275,677 | $275,677 | $273,433 | $273,433 |
| % Margin | 15.6% | 15.6% | 17% | 17% |
| EPS | 0.47 | 0.47 | 0.47 | 0.47 |
| % Growth | 0% | 0% | 0% | – |
| EPS Diluted | 0.47 | 0.47 | 0.47 | 0.47 |
| Weighted Avg Shares Out | 582,217 | 582,217 | 587,245 | 587,245 |
| Weighted Avg Shares Out Dil | 581,326 | 581,326 | 587,244 | 587,244 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10,910 | $10,910 | $0 | $0 |
| Interest Expense | $0 | $0 | $1,053 | $1,053 |
| Depreciation & Amortization | $80,099 | $80,099 | $76,989 | $76,989 |
| EBITDA | $535,679 | $535,679 | $468,041 | $468,041 |
| % Margin | 30.2% | 30.2% | 29.1% | 29.1% |